Evidence map›Paper›PMID 41920312›Full record

ArticleJournal of anesthesia2026

Evaluation of postoperative pain by PainVision® PS-2100, a quantitative analyzer for perception and pain in pulmonary resection: a prospective pilot study.

Tatsuya Masuda, Hideaki Kojima, Tetsuya Mizuno, Akifumi Notsu, Keigo Matsushima, Kensuke Takei, Shuyu Hori, Shoichiro Morizono, Koki Maeda, Toshiyuki Nagata and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tatsuya MasudaDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Hideaki KojimaDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. h.kojima@scchr.jp.
Tetsuya MizunoDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Akifumi NotsuClinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.
Keigo MatsushimaDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Kensuke TakeiDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Shuyu HoriDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Shoichiro MorizonoDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Koki MaedaDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Toshiyuki NagataDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Shinya KatsumataDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Hayato KonnoDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Naoya YokomakuraDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Mitsuhiro IsakaDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Kazushige WakudaDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Toshiaki TakahashiDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Yasuhisa OhdeDivision of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePain intensity is typically assessed using qualitative scales, including the numerical rating scale (NRS), which has limitations in quantifying pain intensity. PainVision® PS-2100 (Nipro Corporation, Osaka, Japan) was developed to quantify pain as pain degree (PD); however, its ability to assess acute postoperative pain remains unclear. This prospective single-center pilot study aimed to evaluate the performance of PainVision® by comparing PD with NRS scores after lung resection surgery.

methodsFifty patients who underwent lobectomy or segmentectomy for lung tumors were enrolled. PD and NRS scores were measured twice daily, at rest and during mobilization, on postoperative days (PODs) 1, 2, 5, and 7. The correlation coefficient between PD and NRS scores on POD 1 was the primary endpoint. Secondary endpoints included the correlation coefficients on PODs 2, 5, and 7; the overall correlation coefficient across all measured data; and a comparison of postoperative trends in PD and NRS scores.

resultsOn POD 1, statistically significant weak-to-moderate positive correlations were observed between PD and NRS scores (r = 0.363-0.634, p < 0.05). Similar results were observed on PODs 2, 5, and 7 in most measurement conditions (r = 0.274-0.664). A statistically significant moderate correlation was observed across all measurements (n = 736; r = 0.575, p < 0.001). PD and NRS scores showed similar trends: values on POD 2 were comparable to POD 1, whereas PODs 5 and 7 were significantly lower.

conclusionPainVision® may be a feasible tool for quantifying acute postoperative pain following lung resection.

Indexed as

Lung cancerNumerical rating scalePain assessmentPainVisionPostoperative pain

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.